APPLICATION
ANDA083856
TYPE
ANDA
ORIGINAL APPROVAL
1977-06-17
LATEST ACTION
1997-11-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ESTRATABDiscontinued
ESTROGENS, ESTERIFIED 1.25MG · TABLET · ORAL
Approval history
1997-11-24Labeling · Supplement 56AP
1997-11-24Labeling · Supplement 40AP
1997-11-24Labeling · Supplement 43AP
1997-06-18Labeling · Supplement 55AP
1992-01-31Labeling · Supplement 51AP
1991-10-02Labeling · Supplement 50AP
1991-01-30Labeling · Supplement 48AP
1989-07-14Labeling · Supplement 47AP
1988-04-06Labeling · Supplement 44AP
1988-04-06Labeling · Supplement 45AP
1987-02-05Labeling · Supplement 34AP
1977-06-17OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.